Record Backlog and Strong Bookings
Q1 bookings of $45M drove backlog to a record $275M, up 54% year-over-year, with a book-to-bill ratio of 1.3 and bookings momentum continuing into early Q2.
Raised Full-Year 2026 Revenue Guidance
Company increased 2026 revenue guidance to $230M–$255M, implying 38%–53% year-over-year growth versus prior year.
Major Contract Wins and Strategic Partnerships
Awarded a preproduction contract with Raytheon on the SM-3 standard missile program and announced a partnership with Anduril on space-based interceptors; selected by NASA for the seventh private astronaut mission (VOYG-1, targeted no earlier than 2028).
Segment Demand Acceleration
Defense & Space Technologies bookings increased 232% year-over-year for the quarter, reflecting strong demand across Golden Dome and other programs; pipeline remains >$5B.
Strong Liquidity Position
Ended Q1 with $429M cash and $212M credit access, totaling $641M in liquidity; plan to upsize credit facility in Q2 to support growth and capital needs.
Large Innovation and R&D Investment
Internally funded R&D (IRAD) was 17% of revenue in Q1 and total innovation spend was 48% (excluding Starlab); company expects IRAD to increase to ~20% of sales for 2026 to accelerate differentiated technologies and AI-enabled manufacturing.
Capacity Build-Outs to Support Scale
Broke ground on a major expansion of the Voyager American Defense Complex (Southern Colorado) and launched the Space Beach facility (Long Beach) to expand manufacturing, electronics and mission hardware throughput.
Starlab Milestones and Funding Progress
Starlab completed a commercial critical design review with NASA, achieved 4 milestones in Q1 and received $24M in NASA milestone payments in the quarter (program-to-date milestone cash receipts $207M); company remains confident in Starlab's long-term commercial potential.